Truist maintains Buy on Albemarle, cuts target to $245

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Truist Securities analyst Peter Osterland maintained a Buy rating on Albemarle (NYSE: ALB) but lowered the price target to $245 from $260.

powered bylight_fuzz_icon
46106062

*this image is generated using AI for illustrative purposes only.

Truist Securities analyst Peter Osterland has maintained a Buy rating on Albemarle (NYSE: ALB) while adjusting the valuation outlook. The firm lowered the price target to $245, down from the previous target of $260.

The revision reflects a reassessment of the stock's potential, though the underlying bullish stance remains unchanged. Investors will note the reduced price target as the primary update in this assessment.

What specific factors led to the reassessment of Albemarle's valuation outlook?

How might this price target adjustment influence investor sentiment towards Albemarle in the short term?

What are the key catalysts that could drive Albemarle's stock toward the revised $245 target?

like16
dislike

Mizuho maintains Neutral on Albemarle, cuts target to $185

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Mizuho analyst John Roberts maintains a Neutral rating on Albemarle and lowers the price target from $205 to $185.

powered bylight_fuzz_icon
44459919

*this image is generated using AI for illustrative purposes only.

Mizuho analyst John Roberts has maintained a Neutral rating on Albemarle while lowering the price target to $185 from $205. The adjustment reflects a revised outlook for the company's stock performance.

The previous price target stood at $205 before this reduction. Albemarle operates under the ticker symbol ALB on the NYSE.

What specific factors led Mizuho to revise Albemarle's outlook?

How might this price target reduction impact investor sentiment toward ALB?

What are the potential risks or opportunities for Albemarle in the current market?

like20
dislike

More News on Albemarle Corp